CN113801863B - A kind of engineering strain of apocynum tannase whole cell catalyst and its preparation method and application - Google Patents
A kind of engineering strain of apocynum tannase whole cell catalyst and its preparation method and application Download PDFInfo
- Publication number
- CN113801863B CN113801863B CN202111097968.7A CN202111097968A CN113801863B CN 113801863 B CN113801863 B CN 113801863B CN 202111097968 A CN202111097968 A CN 202111097968A CN 113801863 B CN113801863 B CN 113801863B
- Authority
- CN
- China
- Prior art keywords
- apocynum
- tannase
- whole
- cell catalyst
- strain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000722949 Apocynum Species 0.000 title claims abstract description 78
- 108010038851 tannase Proteins 0.000 title claims abstract description 46
- 239000003054 catalyst Substances 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 230000001580 bacterial effect Effects 0.000 claims abstract description 21
- 210000002421 cell wall Anatomy 0.000 claims abstract description 8
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 6
- 210000004027 cell Anatomy 0.000 claims description 25
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 16
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 16
- 239000013598 vector Substances 0.000 claims description 16
- 239000002773 nucleotide Substances 0.000 claims description 14
- 125000003729 nucleotide group Chemical group 0.000 claims description 14
- 230000003197 catalytic effect Effects 0.000 claims description 8
- 239000013605 shuttle vector Substances 0.000 claims description 7
- 238000012546 transfer Methods 0.000 claims description 6
- 230000002194 synthesizing effect Effects 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 2
- 244000269722 Thea sinensis Species 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 241001122767 Theaceae Species 0.000 abstract description 16
- 239000000758 substrate Substances 0.000 abstract description 14
- 235000018553 tannin Nutrition 0.000 abstract description 9
- 229920001864 tannin Polymers 0.000 abstract description 9
- 239000001648 tannin Substances 0.000 abstract description 9
- LSHVYAFMTMFKBA-TZIWHRDSSA-N (-)-epicatechin-3-O-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-TZIWHRDSSA-N 0.000 abstract description 8
- LSHVYAFMTMFKBA-UHFFFAOYSA-N ECG Natural products C=1C=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-UHFFFAOYSA-N 0.000 abstract description 8
- 239000013604 expression vector Substances 0.000 abstract description 7
- 239000000796 flavoring agent Substances 0.000 abstract description 6
- 235000019634 flavors Nutrition 0.000 abstract description 6
- 235000019658 bitter taste Nutrition 0.000 abstract description 4
- 230000006698 induction Effects 0.000 abstract description 4
- 238000004873 anchoring Methods 0.000 abstract description 2
- 238000001727 in vivo Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 20
- 238000006243 chemical reaction Methods 0.000 description 19
- 230000000694 effects Effects 0.000 description 16
- 102000004190 Enzymes Human genes 0.000 description 15
- 108090000790 Enzymes Proteins 0.000 description 15
- 239000000047 product Substances 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 238000003752 polymerase chain reaction Methods 0.000 description 12
- 238000000034 method Methods 0.000 description 11
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 10
- 239000002299 complementary DNA Substances 0.000 description 10
- FBSFWRHWHYMIOG-UHFFFAOYSA-N methyl 3,4,5-trihydroxybenzoate Chemical compound COC(=O)C1=CC(O)=C(O)C(O)=C1 FBSFWRHWHYMIOG-UHFFFAOYSA-N 0.000 description 10
- 238000012163 sequencing technique Methods 0.000 description 10
- FFYPMLJYZAEMQB-UHFFFAOYSA-N diethyl pyrocarbonate Chemical compound CCOC(=O)OC(=O)OCC FFYPMLJYZAEMQB-UHFFFAOYSA-N 0.000 description 9
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 241000588724 Escherichia coli Species 0.000 description 7
- 150000001413 amino acids Chemical group 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 6
- 239000006391 Luria-Bertani Medium Substances 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- -1 gallic acid acyl glucose Chemical class 0.000 description 6
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 5
- IBKQQKPQRYUGBJ-UHFFFAOYSA-N methyl gallate Natural products CC(=O)C1=CC(O)=C(O)C(O)=C1 IBKQQKPQRYUGBJ-UHFFFAOYSA-N 0.000 description 5
- 229940075579 propyl gallate Drugs 0.000 description 5
- 235000010388 propyl gallate Nutrition 0.000 description 5
- 239000000473 propyl gallate Substances 0.000 description 5
- 235000014347 soups Nutrition 0.000 description 5
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 102000012410 DNA Ligases Human genes 0.000 description 4
- 108010061982 DNA Ligases Proteins 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 238000001976 enzyme digestion Methods 0.000 description 4
- 229940074391 gallic acid Drugs 0.000 description 4
- 235000004515 gallic acid Nutrition 0.000 description 4
- 229930027917 kanamycin Natural products 0.000 description 4
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 4
- 229960000318 kanamycin Drugs 0.000 description 4
- 229930182823 kanamycin A Natural products 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- 238000011144 upstream manufacturing Methods 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 238000012408 PCR amplification Methods 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 3
- 235000005487 catechin Nutrition 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 238000003259 recombinant expression Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 2
- 241000185686 Apocynum venetum Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- GQFDWEDHOQRNLC-QWRGUYRKSA-N Lys-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN GQFDWEDHOQRNLC-QWRGUYRKSA-N 0.000 description 2
- 102000006382 Ribonucleases Human genes 0.000 description 2
- 108010083644 Ribonucleases Proteins 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 108010047857 aspartylglycine Proteins 0.000 description 2
- 235000019606 astringent taste Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 229950001002 cianidanol Drugs 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 108010034529 leucyl-lysine Proteins 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000008055 phosphate buffer solution Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- LWUWMHIOBPTZBA-DCAQKATOSA-N Ala-Arg-Lys Chemical compound NC(=N)NCCC[C@H](NC(=O)[C@@H](N)C)C(=O)N[C@@H](CCCCN)C(O)=O LWUWMHIOBPTZBA-DCAQKATOSA-N 0.000 description 1
- NIZKGBJVCMRDKO-KWQFWETISA-N Ala-Gly-Tyr Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 NIZKGBJVCMRDKO-KWQFWETISA-N 0.000 description 1
- MDNAVFBZPROEHO-DCAQKATOSA-N Ala-Lys-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O MDNAVFBZPROEHO-DCAQKATOSA-N 0.000 description 1
- MDNAVFBZPROEHO-UHFFFAOYSA-N Ala-Lys-Val Natural products CC(C)C(C(O)=O)NC(=O)C(NC(=O)C(C)N)CCCCN MDNAVFBZPROEHO-UHFFFAOYSA-N 0.000 description 1
- BHTBAVZSZCQZPT-GUBZILKMSA-N Ala-Pro-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N BHTBAVZSZCQZPT-GUBZILKMSA-N 0.000 description 1
- GCTANJIJJROSLH-GVARAGBVSA-N Ala-Tyr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](C)N GCTANJIJJROSLH-GVARAGBVSA-N 0.000 description 1
- SGYSTDWPNPKJPP-GUBZILKMSA-N Arg-Ala-Arg Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O SGYSTDWPNPKJPP-GUBZILKMSA-N 0.000 description 1
- OBFTYSPXDRROQO-SRVKXCTJSA-N Arg-Gln-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCN=C(N)N OBFTYSPXDRROQO-SRVKXCTJSA-N 0.000 description 1
- YRTOMUMWSTUQAX-FXQIFTODSA-N Asn-Pro-Asp Chemical compound NC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O YRTOMUMWSTUQAX-FXQIFTODSA-N 0.000 description 1
- NAPNAGZWHQHZLG-ZLUOBGJFSA-N Asp-Asp-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)N NAPNAGZWHQHZLG-ZLUOBGJFSA-N 0.000 description 1
- VAWNQIGQPUOPQW-ACZMJKKPSA-N Asp-Glu-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O VAWNQIGQPUOPQW-ACZMJKKPSA-N 0.000 description 1
- FAUPLTGRUBTXNU-FXQIFTODSA-N Asp-Pro-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O FAUPLTGRUBTXNU-FXQIFTODSA-N 0.000 description 1
- OZBXOELNJBSJOA-UBHSHLNASA-N Asp-Ser-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)N OZBXOELNJBSJOA-UBHSHLNASA-N 0.000 description 1
- IQCJOIHDVFJQFV-LKXGYXEUSA-N Asp-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC(=O)O)N)O IQCJOIHDVFJQFV-LKXGYXEUSA-N 0.000 description 1
- VHUKCUHLFMRHOD-MELADBBJSA-N Asp-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CC(=O)O)N)C(=O)O VHUKCUHLFMRHOD-MELADBBJSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- YPMDZWPZFOZYFG-GUBZILKMSA-N Gln-Leu-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YPMDZWPZFOZYFG-GUBZILKMSA-N 0.000 description 1
- ATRHMOJQJWPVBQ-DRZSPHRISA-N Glu-Ala-Phe Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O ATRHMOJQJWPVBQ-DRZSPHRISA-N 0.000 description 1
- MXOODARRORARSU-ACZMJKKPSA-N Glu-Ala-Ser Chemical compound C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCC(=O)O)N MXOODARRORARSU-ACZMJKKPSA-N 0.000 description 1
- CUXJIASLBRJOFV-LAEOZQHASA-N Glu-Gly-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(O)=O CUXJIASLBRJOFV-LAEOZQHASA-N 0.000 description 1
- WTMZXOPHTIVFCP-QEWYBTABSA-N Glu-Ile-Phe Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 WTMZXOPHTIVFCP-QEWYBTABSA-N 0.000 description 1
- DNPCBMNFQVTHMA-DCAQKATOSA-N Glu-Leu-Gln Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O DNPCBMNFQVTHMA-DCAQKATOSA-N 0.000 description 1
- LKOAAMXDJGEYMS-ZPFDUUQYSA-N Glu-Met-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O LKOAAMXDJGEYMS-ZPFDUUQYSA-N 0.000 description 1
- UDEPRBFQTWGLCW-CIUDSAMLSA-N Glu-Pro-Asp Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O UDEPRBFQTWGLCW-CIUDSAMLSA-N 0.000 description 1
- GUOWMVFLAJNPDY-CIUDSAMLSA-N Glu-Ser-Met Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(O)=O GUOWMVFLAJNPDY-CIUDSAMLSA-N 0.000 description 1
- WXONSNSSBYQGNN-AVGNSLFASA-N Glu-Ser-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O WXONSNSSBYQGNN-AVGNSLFASA-N 0.000 description 1
- UZWUBBRJWFTHTD-LAEOZQHASA-N Glu-Val-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCC(O)=O UZWUBBRJWFTHTD-LAEOZQHASA-N 0.000 description 1
- PUUYVMYCMIWHFE-BQBZGAKWSA-N Gly-Ala-Arg Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N PUUYVMYCMIWHFE-BQBZGAKWSA-N 0.000 description 1
- FMVLWTYYODVFRG-BQBZGAKWSA-N Gly-Asn-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)CN FMVLWTYYODVFRG-BQBZGAKWSA-N 0.000 description 1
- CCQOOWAONKGYKQ-BYPYZUCNSA-N Gly-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)CN CCQOOWAONKGYKQ-BYPYZUCNSA-N 0.000 description 1
- SWQALSGKVLYKDT-UHFFFAOYSA-N Gly-Ile-Ala Natural products NCC(=O)NC(C(C)CC)C(=O)NC(C)C(O)=O SWQALSGKVLYKDT-UHFFFAOYSA-N 0.000 description 1
- LIXWIUAORXJNBH-QWRGUYRKSA-N Gly-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)CN LIXWIUAORXJNBH-QWRGUYRKSA-N 0.000 description 1
- IGOYNRWLWHWAQO-JTQLQIEISA-N Gly-Phe-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)CN)CC1=CC=CC=C1 IGOYNRWLWHWAQO-JTQLQIEISA-N 0.000 description 1
- HQSKKSLNLSTONK-JTQLQIEISA-N Gly-Tyr-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)CN)CC1=CC=C(O)C=C1 HQSKKSLNLSTONK-JTQLQIEISA-N 0.000 description 1
- UXSATKFPUVZVDK-KKUMJFAQSA-N His-Lys-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC1=CN=CN1)N UXSATKFPUVZVDK-KKUMJFAQSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- VAXBXNPRXPHGHG-BJDJZHNGSA-N Ile-Ala-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)N VAXBXNPRXPHGHG-BJDJZHNGSA-N 0.000 description 1
- JQLFYZMEXFNRFS-DJFWLOJKSA-N Ile-Asp-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N JQLFYZMEXFNRFS-DJFWLOJKSA-N 0.000 description 1
- LGMUPVWZEYYUMU-YVNDNENWSA-N Ile-Glu-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N LGMUPVWZEYYUMU-YVNDNENWSA-N 0.000 description 1
- VOBYAKCXGQQFLR-LSJOCFKGSA-N Ile-Gly-Val Chemical compound CC[C@H](C)[C@H](N)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O VOBYAKCXGQQFLR-LSJOCFKGSA-N 0.000 description 1
- PWDSHAAAFXISLE-SXTJYALSSA-N Ile-Ile-Asp Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(O)=O PWDSHAAAFXISLE-SXTJYALSSA-N 0.000 description 1
- PFPUFNLHBXKPHY-HTFCKZLJSA-N Ile-Ile-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)O)N PFPUFNLHBXKPHY-HTFCKZLJSA-N 0.000 description 1
- PWUMCBLVWPCKNO-MGHWNKPDSA-N Ile-Leu-Tyr Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 PWUMCBLVWPCKNO-MGHWNKPDSA-N 0.000 description 1
- DSDPLOODKXISDT-XUXIUFHCSA-N Ile-Leu-Val Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O DSDPLOODKXISDT-XUXIUFHCSA-N 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- FADYJNXDPBKVCA-UHFFFAOYSA-N L-Phenylalanyl-L-lysin Natural products NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 1
- 239000012880 LB liquid culture medium Substances 0.000 description 1
- 241000880493 Leptailurus serval Species 0.000 description 1
- XBBKIIGCUMBKCO-JXUBOQSCSA-N Leu-Ala-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XBBKIIGCUMBKCO-JXUBOQSCSA-N 0.000 description 1
- STAVRDQLZOTNKJ-RHYQMDGZSA-N Leu-Arg-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O STAVRDQLZOTNKJ-RHYQMDGZSA-N 0.000 description 1
- FIJMQLGQLBLBOL-HJGDQZAQSA-N Leu-Asn-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O FIJMQLGQLBLBOL-HJGDQZAQSA-N 0.000 description 1
- BPANDPNDMJHFEV-CIUDSAMLSA-N Leu-Asp-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O BPANDPNDMJHFEV-CIUDSAMLSA-N 0.000 description 1
- CFZZDVMBRYFFNU-QWRGUYRKSA-N Leu-His-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)NCC(O)=O CFZZDVMBRYFFNU-QWRGUYRKSA-N 0.000 description 1
- QNBVTHNJGCOVFA-AVGNSLFASA-N Leu-Leu-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCC(O)=O QNBVTHNJGCOVFA-AVGNSLFASA-N 0.000 description 1
- FAELBUXXFQLUAX-AJNGGQMLSA-N Leu-Leu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C FAELBUXXFQLUAX-AJNGGQMLSA-N 0.000 description 1
- LZHJZLHSRGWBBE-IHRRRGAJSA-N Leu-Lys-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O LZHJZLHSRGWBBE-IHRRRGAJSA-N 0.000 description 1
- INCJJHQRZGQLFC-KBPBESRZSA-N Leu-Phe-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(O)=O INCJJHQRZGQLFC-KBPBESRZSA-N 0.000 description 1
- PJWOOBTYQNNRBF-BZSNNMDCSA-N Leu-Phe-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)O)N PJWOOBTYQNNRBF-BZSNNMDCSA-N 0.000 description 1
- QMKFDEUJGYNFMC-AVGNSLFASA-N Leu-Pro-Arg Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O QMKFDEUJGYNFMC-AVGNSLFASA-N 0.000 description 1
- CHJKEDSZNSONPS-DCAQKATOSA-N Leu-Pro-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O CHJKEDSZNSONPS-DCAQKATOSA-N 0.000 description 1
- IZPVWNSAVUQBGP-CIUDSAMLSA-N Leu-Ser-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O IZPVWNSAVUQBGP-CIUDSAMLSA-N 0.000 description 1
- VJGQRELPQWNURN-JYJNAYRXSA-N Leu-Tyr-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O VJGQRELPQWNURN-JYJNAYRXSA-N 0.000 description 1
- CGHXMODRYJISSK-NHCYSSNCSA-N Leu-Val-Asp Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC(O)=O CGHXMODRYJISSK-NHCYSSNCSA-N 0.000 description 1
- MPGHETGWWWUHPY-CIUDSAMLSA-N Lys-Ala-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN MPGHETGWWWUHPY-CIUDSAMLSA-N 0.000 description 1
- UWKNTTJNVSYXPC-CIUDSAMLSA-N Lys-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN UWKNTTJNVSYXPC-CIUDSAMLSA-N 0.000 description 1
- WGCKDDHUFPQSMZ-ZPFDUUQYSA-N Lys-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CCCCN WGCKDDHUFPQSMZ-ZPFDUUQYSA-N 0.000 description 1
- MQMIRLVJXQNTRJ-SDDRHHMPSA-N Lys-Gln-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCCN)N)C(=O)O MQMIRLVJXQNTRJ-SDDRHHMPSA-N 0.000 description 1
- HVAUKHLDSDDROB-KKUMJFAQSA-N Lys-Lys-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O HVAUKHLDSDDROB-KKUMJFAQSA-N 0.000 description 1
- MTBLFIQZECOEBY-IHRRRGAJSA-N Lys-Met-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(O)=O MTBLFIQZECOEBY-IHRRRGAJSA-N 0.000 description 1
- AFLBTVGQCQLOFJ-AVGNSLFASA-N Lys-Pro-Arg Chemical compound NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O AFLBTVGQCQLOFJ-AVGNSLFASA-N 0.000 description 1
- PELXPRPDQRFBGQ-KKUMJFAQSA-N Lys-Tyr-Asn Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCCCN)N)O PELXPRPDQRFBGQ-KKUMJFAQSA-N 0.000 description 1
- BWECSLVQIWEMSC-IHRRRGAJSA-N Lys-Val-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CCCCN)N BWECSLVQIWEMSC-IHRRRGAJSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- JACAKCWAOHKQBV-UWVGGRQHSA-N Met-Gly-Lys Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCCN JACAKCWAOHKQBV-UWVGGRQHSA-N 0.000 description 1
- ZGVYWHODYWRPLK-GUBZILKMSA-N Met-Pro-Cys Chemical compound CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(O)=O ZGVYWHODYWRPLK-GUBZILKMSA-N 0.000 description 1
- 108010002311 N-glycylglutamic acid Proteins 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- QEPZQAPZKIPVDV-KKUMJFAQSA-N Phe-Cys-His Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N QEPZQAPZKIPVDV-KKUMJFAQSA-N 0.000 description 1
- JEBWZLWTRPZQRX-QWRGUYRKSA-N Phe-Gly-Asp Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O JEBWZLWTRPZQRX-QWRGUYRKSA-N 0.000 description 1
- CBENHWCORLVGEQ-HJOGWXRNSA-N Phe-Phe-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CBENHWCORLVGEQ-HJOGWXRNSA-N 0.000 description 1
- MMJJFXWMCMJMQA-STQMWFEESA-N Phe-Pro-Gly Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)NCC(O)=O)C1=CC=CC=C1 MMJJFXWMCMJMQA-STQMWFEESA-N 0.000 description 1
- MCIXMYKSPQUMJG-SRVKXCTJSA-N Phe-Ser-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O MCIXMYKSPQUMJG-SRVKXCTJSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- VOHFZDSRPZLXLH-IHRRRGAJSA-N Pro-Asn-Phe Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O VOHFZDSRPZLXLH-IHRRRGAJSA-N 0.000 description 1
- OFGUOWQVEGTVNU-DCAQKATOSA-N Pro-Lys-Ala Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O OFGUOWQVEGTVNU-DCAQKATOSA-N 0.000 description 1
- 238000010802 RNA extraction kit Methods 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- WUXCHQZLUHBSDJ-LKXGYXEUSA-N Ser-Thr-Asp Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(O)=O)C(O)=O WUXCHQZLUHBSDJ-LKXGYXEUSA-N 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- VUVCRYXYUUPGSB-GLLZPBPUSA-N Thr-Gln-Glu Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N)O VUVCRYXYUUPGSB-GLLZPBPUSA-N 0.000 description 1
- SLUWOCTZVGMURC-BFHQHQDPSA-N Thr-Gly-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)NCC(=O)N[C@@H](C)C(O)=O SLUWOCTZVGMURC-BFHQHQDPSA-N 0.000 description 1
- VTVVYQOXJCZVEB-WDCWCFNPSA-N Thr-Leu-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O VTVVYQOXJCZVEB-WDCWCFNPSA-N 0.000 description 1
- XSEPSRUDSPHMPX-KATARQTJSA-N Thr-Lys-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O XSEPSRUDSPHMPX-KATARQTJSA-N 0.000 description 1
- GWBWCGITOYODER-YTQUADARSA-N Trp-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N GWBWCGITOYODER-YTQUADARSA-N 0.000 description 1
- JHORGUYURUBVOM-KKUMJFAQSA-N Tyr-His-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O JHORGUYURUBVOM-KKUMJFAQSA-N 0.000 description 1
- MXFPBNFKVBHIRW-BZSNNMDCSA-N Tyr-Lys-His Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N)O MXFPBNFKVBHIRW-BZSNNMDCSA-N 0.000 description 1
- NHOVZGFNTGMYMI-KKUMJFAQSA-N Tyr-Ser-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NHOVZGFNTGMYMI-KKUMJFAQSA-N 0.000 description 1
- ZLFHAAGHGQBQQN-GUBZILKMSA-N Val-Ala-Pro Natural products CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O ZLFHAAGHGQBQQN-GUBZILKMSA-N 0.000 description 1
- ZMDCGGKHRKNWKD-LAEOZQHASA-N Val-Asn-Glu Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N ZMDCGGKHRKNWKD-LAEOZQHASA-N 0.000 description 1
- MHAHQDBEIDPFQS-NHCYSSNCSA-N Val-Glu-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)C(C)C MHAHQDBEIDPFQS-NHCYSSNCSA-N 0.000 description 1
- CPGJELLYDQEDRK-NAKRPEOUSA-N Val-Ile-Ala Chemical compound CC[C@H](C)[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(O)=O CPGJELLYDQEDRK-NAKRPEOUSA-N 0.000 description 1
- VXDSPJJQUQDCKH-UKJIMTQDSA-N Val-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N VXDSPJJQUQDCKH-UKJIMTQDSA-N 0.000 description 1
- APQIVBCUIUDSMB-OSUNSFLBSA-N Val-Ile-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](C(C)C)N APQIVBCUIUDSMB-OSUNSFLBSA-N 0.000 description 1
- KTEZUXISLQTDDQ-NHCYSSNCSA-N Val-Lys-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)N KTEZUXISLQTDDQ-NHCYSSNCSA-N 0.000 description 1
- LJSZPMSUYKKKCP-UBHSHLNASA-N Val-Phe-Ala Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CC1=CC=CC=C1 LJSZPMSUYKKKCP-UBHSHLNASA-N 0.000 description 1
- GQMNEJMFMCJJTD-NHCYSSNCSA-N Val-Pro-Gln Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O GQMNEJMFMCJJTD-NHCYSSNCSA-N 0.000 description 1
- VHIZXDZMTDVFGX-DCAQKATOSA-N Val-Ser-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)N VHIZXDZMTDVFGX-DCAQKATOSA-N 0.000 description 1
- QTPQHINADBYBNA-DCAQKATOSA-N Val-Ser-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN QTPQHINADBYBNA-DCAQKATOSA-N 0.000 description 1
- XNLUVJPMPAZHCY-JYJNAYRXSA-N Val-Val-Phe Chemical compound CC(C)[C@H]([NH3+])C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C([O-])=O)CC1=CC=CC=C1 XNLUVJPMPAZHCY-JYJNAYRXSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 108010047495 alanylglycine Proteins 0.000 description 1
- 108010070944 alanylhistidine Proteins 0.000 description 1
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 1
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 1
- 108010038633 aspartylglutamate Proteins 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- YTRQFSDWAXHJCC-UHFFFAOYSA-N chloroform;phenol Chemical group ClC(Cl)Cl.OC1=CC=CC=C1 YTRQFSDWAXHJCC-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000006353 environmental stress Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 1
- 235000012734 epicatechin Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 1
- 108010090037 glycyl-alanyl-isoleucine Proteins 0.000 description 1
- 108010050848 glycylleucine Proteins 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 108010036413 histidylglycine Proteins 0.000 description 1
- 108010025306 histidylleucine Proteins 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 108010057821 leucylproline Proteins 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 238000000464 low-speed centrifugation Methods 0.000 description 1
- 108010009298 lysylglutamic acid Proteins 0.000 description 1
- 108010038320 lysylphenylalanine Proteins 0.000 description 1
- 108010017391 lysylvaline Proteins 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 108010065135 phenylalanyl-phenylalanyl-phenylalanine Proteins 0.000 description 1
- 108010073025 phenylalanylphenylalanine Proteins 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 108010070643 prolylglutamic acid Proteins 0.000 description 1
- 108010029020 prolylglycine Proteins 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000003161 ribonuclease inhibitor Substances 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/01—Carboxylic ester hydrolases (3.1.1)
- C12Y301/0102—Tannase (3.1.1.20)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明涉及生物工程技术领域,特别涉及一种罗布麻单宁酶全细胞催化剂工程菌株及其制备方法和应用。罗布麻单宁酶全细胞催化剂工程菌株包含SEQ ID NO:1所示的罗布麻单宁酶基因,可表达SEQ ID NO:2所示的罗布麻单宁酶。本发明从草本植物罗布麻体内克隆获得新的单宁酶基因,构建穿梭表达载体,并经诱导获得细胞壁表面锚定罗布麻单宁酶的全细胞催化剂工程菌株。该全细胞催化剂工程菌株具较高的耐热性,能催化表儿茶素没食子酸酯等单宁底物,并去除罗布麻茶苦涩味,明显改进罗布麻茶风味,具有广阔的应用前景。The invention relates to the technical field of bioengineering, in particular to an engineering strain of apocynum tannase whole-cell catalyst and its preparation method and application. The whole-cell catalyst engineering strain of apocynum tanninase comprises the gene of apocynum tanninase shown in SEQ ID NO:1, and can express the apocynum tanninase shown in SEQ ID NO:2. The invention clones and obtains a new tannase gene from the herb plant Apocynum apocynum in vivo, constructs a shuttle expression vector, and obtains a whole-cell catalyst engineering bacterial strain anchoring the apocynum tannase on the cell wall surface through induction. The whole-cell catalyst engineering strain has high heat resistance, can catalyze tannin substrates such as epicatechin gallate, remove the bitter taste of apocynum tea, obviously improve the flavor of apocynum tea, and has broad application prospects.
Description
技术领域technical field
本发明涉及生物工程技术领域,特别涉及一种罗布麻单宁酶全细胞催化剂工程菌株及其制备方法和应用。The invention relates to the technical field of bioengineering, in particular to an engineering strain of apocynum tannase whole-cell catalyst and its preparation method and application.
背景技术Background technique
野生的植物“罗布麻”(学名:A.venetum L.)具有清除血管壁沉积物、软化血管、降压清脂、常年稳压的作用。自古以来,罗布麻就在国人的生活中发挥着极为特殊的健康作用。根据《本草纲目》、《救荒本草》等古药典记载,罗布麻茶有平心悸、止眩晕、消痰止咳、强心利尿之功能,用开水冲泡后,色绿清淡,味道苦,涩,酸,可抑制血压升高,并对高血压患者的血压进行降低的作用,但罗布麻茶中单宁类物质含量过多,容易导致茶叶苦涩味加重,影响风味。The wild plant "Apocynum venetum" (scientific name: A. venetum L.) has the functions of clearing blood vessel wall deposits, softening blood vessels, lowering blood pressure and clearing fat, and stabilizing blood pressure all year round. Since ancient times, apocynum has played a very special role in health in the lives of Chinese people. According to ancient pharmacopoeia records such as "Compendium of Materia Medica", "Compendium of Materia Medica" and other ancient pharmacopoeias, Apocynum tea has the functions of calming palpitations, stopping dizziness, eliminating phlegm and relieving cough, and strengthening the heart and diuresis. After brewing with boiling water, the color is green and light, and the taste is bitter and astringent. Sour, can inhibit the increase of blood pressure, and lower the blood pressure of hypertensive patients, but the content of tannins in Apocynum tea is too much, which will easily lead to the aggravation of bitterness and astringency of tea and affect the flavor.
单宁是植物中普遍存在的酚类化合物,是植物在生存适应过程中为了抵御病毒、菌类等微生物或环境的胁迫而形成的一种次生代谢产物,它们广泛地积累于茶叶、水果、蔬菜等各种植物性食品中,是决定涩味的主要化合物。长期以来,有关控制植物单宁化合物的合成及水解途径的关键基因尚不清楚,成为国内外植物界高度关注的研究热点。目前,还未见罗布麻中单宁酶(Tannse,EC3.1.1.20,TA)及其基因和应用的报道。Tannin is a phenolic compound ubiquitous in plants. It is a secondary metabolite formed by plants in the process of survival and adaptation to resist microorganisms such as viruses and fungi or environmental stress. They are widely accumulated in tea, fruits, In various plant foods such as vegetables, it is the main compound that determines the astringency. For a long time, the key genes that control the synthesis and hydrolysis pathways of plant tannins have not been clear, and have become a research hotspot of great concern in the plant community at home and abroad. At present, there is no report on tannase (Tannse, EC3.1.1.20, TA) and its gene and application in Apocynum apocynum.
发明内容Contents of the invention
有鉴于此,本发明提供了一种罗布麻单宁酶全细胞催化剂工程菌株及其制备方法和应用。该全细胞催化剂工程菌株能催化水解表儿茶素没食子酸、没食子酸甲酯、没食子酸酰基葡萄糖、没食子酸丙酯等单宁底物,改善罗布麻茶风味。In view of this, the present invention provides an engineering strain of apocynum tannase whole-cell catalyst and its preparation method and application. The whole-cell catalyst engineering strain can catalyze the hydrolysis of tannin substrates such as epicatechin gallic acid, methyl gallate, gallic acid acyl glucose, propyl gallate, etc., and improve the flavor of apocynum tea.
为了实现上述发明目的,本发明提供以下技术方案:In order to achieve the above-mentioned purpose of the invention, the present invention provides the following technical solutions:
本发明提供了一种罗布麻单宁酶基因,该罗布麻单宁酶基因为SEQ ID NO:1所示的核苷酸序列。The invention provides an apocynum tannase gene, which is the nucleotide sequence shown in SEQ ID NO:1.
本发明还提供了一种罗布麻单宁酶基因,该罗布麻单宁酶基因为与SEQ ID NO:1所示核苷酸序列同源性达80%以上的核苷酸序列。The present invention also provides an apocynum tannase gene, which is a nucleotide sequence with more than 80% homology with the nucleotide sequence shown in SEQ ID NO:1.
本发明还提供了一种罗布麻单宁酶,该罗布麻单宁酶为SEQ ID NO:2所示的氨基酸序列。The present invention also provides an apocynum tannase, which has the amino acid sequence shown in SEQ ID NO:2.
本发明还提供了一种重组载体,重组载体包含上述罗布麻单宁酶基因和穿梭载体。The present invention also provides a recombinant vector, which comprises the above-mentioned apocynum tannase gene and a shuttle vector.
在本发明中,穿梭载体为pYD1。In the present invention, the shuttle vector is pYD1.
本发明还提供了一种罗布麻单宁酶全细胞催化剂工程菌株,该工程菌株包含上述重组载体和基础菌株。The present invention also provides an engineering strain of the whole-cell catalyst of apocynum tannase, which comprises the above-mentioned recombinant vector and the basic strain.
在本发明中,基础菌株为酿酒酵母。In the present invention, the basic strain is Saccharomyces cerevisiae.
本发明还提供了该罗布麻单宁酶全细胞催化剂工程菌株的制备方法,包括以下步骤:The present invention also provides the preparation method of this apocynum tannase whole-cell catalyst engineering strain, comprising the following steps:
步骤一、合成SEQ ID NO:1所示的核苷酸序列;
步骤二、将SEQ ID NO:1所示的核苷酸序列插入穿梭载体,得到重组载体;
步骤三、将重组载体转入基础菌株,得到重组菌株;
步骤四、将重组菌株进行诱导表达,获得细胞壁表面锚定氨基酸序列如SEQ IDNO:2所示罗布麻单宁酶的全细胞催化工程菌株。
本发明还提供了该罗布麻单宁酶全细胞催化剂工程菌株在制备罗布麻茶中的应用。The invention also provides the application of the apocynum tannase whole-cell catalyst engineering strain in preparing apocynum tea.
本发明还提供了一种罗布麻茶,其原料包括罗布麻叶和罗布麻单宁酶全细胞催化剂工程菌株。The invention also provides an apocynum tea, the raw material of which comprises apocynum leaves and an engineering strain of apocynum tannase whole-cell catalyst.
本发明提供了一种罗布麻单宁酶全细胞催化剂工程菌株及其制备方法和应用。罗布麻单宁酶全细胞催化剂工程菌株包含SEQ ID NO:1所示的罗布麻单宁酶基因,可表达SEQID NO:2所示的罗布麻单宁酶。本发明的有益效果:The invention provides an engineering strain of apocynum tannase whole-cell catalyst and its preparation method and application. The apocynum tannase whole-cell catalyst engineering strain comprises the apocynum tannase gene shown in SEQ ID NO:1, and can express the apocynum tannase shown in SEQ ID NO:2. Beneficial effects of the present invention:
本发明重组罗布麻单宁酶全细胞催化剂工程菌株可改善罗布麻茶风味。将罗布麻单宁酶全细胞催化剂工程菌株作用于罗布麻茶汤,可降低酯型儿茶素的含量,消除部分苦涩味;增加铁、钙、镁和锌等离子的溶解度,以及茶汤中固形物和浸提物产量。The recombinant apocynum tannase whole-cell catalyst engineering strain of the invention can improve the flavor of apocynum tea. The whole-cell catalyst engineering strain of apocynum tannase acts on apocynum tea soup, which can reduce the content of ester catechins and eliminate part of the bitter taste; increase the solubility of iron, calcium, magnesium and zinc plasma, as well as the solid content and Extract yield.
罗布麻单宁酶全细胞催化剂的最适反应温度80℃,在80℃以下时酶活稳定性较高,表现出85%以上的相对剩余酶活力。通过将罗布麻植物来源的单宁酶锚定在酿酒酵母细胞壁表面,形成的全细胞催化剂菌株对表儿茶素没食子酸酯具高催化活性,其耐热性明显高于已报道的其他植物或真菌来源单宁酶。The optimal reaction temperature of the whole-cell catalyst of Apocynum tanninase is 80°C, and the stability of the enzyme activity is higher when the temperature is below 80°C, showing a relative remaining enzyme activity of more than 85%. By anchoring the tannase derived from the Apocynum plant on the surface of the cell wall of Saccharomyces cerevisiae, the whole-cell catalyst strain formed has high catalytic activity towards epicatechin gallate, and its heat resistance is significantly higher than that of other reported plants or Tannase of fungal origin.
此外,将罗布麻植物来源的单宁酶锚定在酿酒酵母细胞壁表面,酶促反应后通过4000转/分钟低速离心,可回收60-70%的全细胞催化剂菌株,实现酶的固化与循环利用。In addition, the tannase derived from the apocynum plant is anchored on the surface of the cell wall of Saccharomyces cerevisiae, and after the enzymatic reaction, 60-70% of the whole-cell catalyst strain can be recovered by low-speed centrifugation at 4000 rpm, realizing the solidification and recycling of the enzyme .
附图说明Description of drawings
图1为实施例2一种罗布麻单宁酶全细胞催化剂工程菌株底物活性分析;Fig. 1 is a kind of apocynum tannase whole cell catalyst engineering strain substrate activity analysis of
图2和图3为实施例3一种罗布麻单宁酶全细胞催化剂工程菌株酶活力稳定性分析。Figure 2 and Figure 3 are the enzyme activity stability analysis of a kind of Apocynum tannase whole cell catalyst engineering strain in Example 3.
具体实施方式Detailed ways
本发明公开了一种罗布麻单宁酶全细胞催化剂工程菌株及其制备方法和应用,本领域技术人员可以借鉴本文内容,适当改进工艺参数实现。特别需要指出的是,所有类似的替换和改动对本领域技术人员来说是显而易见的,它们都被视为包括在本发明。本发明的方法及应用已经通过较佳实施例进行了描述,相关人员明显能在不脱离本发明内容、精神和范围内对本文所述的方法和应用进行改动或适当变更与组合,来实现和应用本发明技术。The invention discloses an engineering strain of apocynum tannase whole-cell catalyst and its preparation method and application. Those skilled in the art can learn from the content of this article and appropriately improve the process parameters to realize it. In particular, it should be pointed out that all similar replacements and modifications are obvious to those skilled in the art, and they are all considered to be included in the present invention. The method and application of the present invention have been described through preferred embodiments, and the relevant personnel can obviously make changes or appropriate changes and combinations to the method and application described herein without departing from the content, spirit and scope of the present invention to realize and Apply the technology of the present invention.
本发明这种制备罗布麻单宁酶的方法,包括以下步骤:The method for preparing Apocynum tanninase of the present invention comprises the following steps:
步骤一、合成序列表SEQ ID NO:1所示的核苷酸序列;
步骤二、根据步骤一的核苷酸序列,构建pYD1-avta穿梭载体并转化大肠杆菌,验证后通过大肠杆菌扩繁于质粒提取获得大量重组pYD1-avta载体;
步骤三、将步骤二获得的pYD1-avta载体转化酿酒酵母EBY100菌株,并进行诱导表达,获得细胞壁表面锚定氨基酸序列如SEQ ID NO:2所示罗布麻单宁酶的酿酒酵母全细胞催化工程菌株。
步骤四、将pYD1-avta/S.cerevisiae EBY100全细胞催化剂工程菌株进行诱导表达,分别以表儿茶素没食子酸、没食子酸甲酯、没食子酸酰基葡萄糖、没食子酸丙酯等为底物,开展其底物特性与酶学性质检测。
所述步骤一的具体方法,包括以下步骤:The concrete method of described
1)从罗布麻叶样品中提取总RNA,并用反转录酶合成cDNA(互补脱氧核糖核酸)第一链;1) total RNA is extracted from the Apocynum leaf sample, and the first strand of cDNA (complementary deoxyribonucleic acid) is synthesized with reverse transcriptase;
2)以cDNA为模板,利用上游引物1和下游引物2进行PCR(聚合酶链式反应)扩增;2) using cDNA as a template, using upstream
上游引物1:5’GGAATTCATGGGTTGCCCTTGTGGAAAC3’Upstream primer 1: 5'G GAATTC ATGGGTTGCCCTTGTGGAAAC3'
下游引物2:5’CAAGCTTTTGATTGCAAGAGCAGCTTGAG3’Downstream primer 2: 5'C AAGCTT TTGATTGCAAGAGCAGCTTGAG3'
PCR的反应体系为:2μL cDNA模板,25μL 2×PrimerSTAR Max DNA Polymerase,1μL上游引物1,1μL下游引物2,补ddH2O(双蒸水)至总反应体系为50μL;PCR的反应条件为:①94℃,5min;②94℃,15s;③55℃,15s;④72℃,30s;⑤重复步骤②-④25个循环;⑥72℃,10min;The PCR reaction system is: 2 μL cDNA template, 25
3)PCR产物经纯化回收后测序,得到如序列表SEQ ID NO:1所示碱基序列。3) The PCR product is sequenced after purification and recovery, and the base sequence shown in SEQ ID NO: 1 in the sequence table is obtained.
所述步骤二中,重组表达载体的载体骨架为pYD1穿梭表达载体;穿梭菌株为大肠杆菌Top10;全细胞催化剂工程菌株为酿酒酵母(EBY100)。In the second step, the vector backbone of the recombinant expression vector is the pYD1 shuttle expression vector; the shuttle strain is Escherichia coli Top10; the whole-cell catalyst engineering strain is Saccharomyces cerevisiae (EBY100).
所述步骤二的具体方法,包括以下步骤:The concrete method of described
1)将得到的核苷酸序列与pYD1穿梭表达载体分别进行双酶切,双酶切产物经纯化回收后与T4 DNA连接酶进行连接,得到重组载体连接产物;1) Carry out double digestion of the obtained nucleotide sequence and the pYD1 shuttle expression vector, and the double digestion products are purified and recovered, and then ligated with T4 DNA ligase to obtain the recombinant vector ligation product;
2)将重组表达载体连接产物与大肠杆菌感受态细胞(E.coli DH5α)混匀,放置在冰浴中20min,42℃水浴下90s,取出后再次冰浴5min;接着将其加入到LB(Luria-Bertani培养基)液体培养基,并在37℃,150rpm条件下,振荡培养1h;取菌液于含50mg/L卡那霉素的LB固体培养基,涂布均匀,在37℃过夜培养,获得克隆菌落;2) Mix the ligation product of the recombinant expression vector with Escherichia coli competent cells (E.coli DH5α), place it in an ice bath for 20 minutes, put it in a water bath at 42°C for 90 seconds, take it out and put it in an ice bath for 5 minutes again; then add it to LB ( Luria-Bertani medium) liquid medium, and at 37°C, under the condition of 150rpm, shake culture for 1h; take the bacterial liquid in LB solid medium containing 50mg/L kanamycin, spread evenly, and cultivate overnight at 37°C , to obtain clonal colonies;
3)挑取单克隆菌落接种于含卡那霉素的LB培养液中,并在37℃、250rpm条件振荡过夜,取菌液进行菌落PCR初步鉴定,将阳性菌液抽提质粒(pYD1-avta)进一步酶切(EcoRI/HindIII)鉴定正确后送样测序,获得测序正确的重组工程菌株;3) Pick a monoclonal colony and inoculate it in LB culture medium containing kanamycin, shake overnight at 37°C and 250rpm, take the bacterial solution for preliminary identification by colony PCR, and extract the plasmid (pYD1-avta ) After further enzyme digestion (EcoRI/HindIII) identification is correct, send the sample for sequencing, and obtain the recombinant engineering strain with correct sequencing;
4)挑取测序正确的重组工程菌株扩繁后,大量提取pYD1-avta重组载体。4) After the recombinant engineering strains with correct sequencing were selected and multiplied, a large number of pYD1-avta recombinant vectors were extracted.
所述步骤三的具体方法,包括以下步骤:The concrete method of described
1)将约2μg的pYD1-avta重组载体与50μL酿酒酵母EBY100感受态细胞混合均匀后,于1.5kV、25μF、200Ω条件下进行电击转化;1) After mixing about 2 μg of the pYD1-avta recombinant vector with 50 μL of Saccharomyces cerevisiae EBY100 competent cells, conduct electric shock transformation under the conditions of 1.5kV, 25μF, and 200Ω;
2)将上述转化溶液接种到10mL SD-CAA培养基中30℃、250rpm过夜培养至菌液浓度OD600值达2~5。室温,5,000rpm离心5min收集菌体,并转移至20~40mL的SG-CAA诱导培养基中,20℃~25℃、250rpm诱导培养48h,然后取诱导后的菌体分别进行菌落PCR测序、免疫荧光及western-blotting等验证。获得细胞壁表面锚定氨基酸序列如SEQ ID NO:2所示罗布麻单宁酶的酿酒酵母全细胞催化剂工程菌株。2) The above transformation solution was inoculated into 10 mL of SD-CAA medium and cultured overnight at 30°C and 250 rpm until the OD600 value of the bacterial solution concentration reached 2-5. Centrifuge at room temperature at 5,000rpm for 5min to collect the bacterial cells, transfer them to 20-40mL SG-CAA induction medium, induce culture at 20°C-25°C, 250rpm for 48h, and then take the induced bacterial cells for colony PCR sequencing, immunization Fluorescence and western-blotting verification. The whole cell catalyst engineering strain of Saccharomyces cerevisiae whose cell wall surface anchored amino acid sequence as shown in SEQ ID NO: 2 was obtained.
所述步骤四的具体方法,包括以下步骤:The concrete method of described
取1μgpYD1-avta/S.cerevisiae EBY100全细胞催化剂工程菌株,分别加入终浓度为0.2mM的维生素C溶液、终浓度为300μM的表儿茶素没食子酸酯、没食子酸酰葡萄糖、没食子酸甲酯、没食子酸丙酯等底物溶液、以及PH7.4的磷酸缓冲溶液,至总反应体系为50μL;35℃,反应10min后,加入50μL甲醇反应终止液;4℃、12000g、离心15min后,取上清液进行液相色谱分析,检测反应后溶液中的底物以及相应产物的种类与含量。Take 1 μg pYD1-avta/S.cerevisiae EBY100 whole-cell catalyst engineering strain, add vitamin C solution with a final concentration of 0.2mM, epicatechin gallate, gallic acid acylglucose, methyl gallate, and a final concentration of 300μM, respectively. Substrate solution such as propyl gallate and phosphate buffer solution with pH 7.4, until the total reaction system is 50 μL; after 10 minutes of reaction at 35°C, 50 μL of methanol reaction termination solution was added; after centrifugation at 12000g at 4°C for 15 minutes, the upper The clear liquid was analyzed by liquid chromatography to detect the types and contents of substrates and corresponding products in the solution after the reaction.
以催化活性最高的特定单宁为底物,在最适pH值条件下,于10~90℃的温度范围内测定重组酵母全细胞的最适反应温度;同样,将重组酵母全细胞在不同温度条件下处理1h后,测定不同温度处理后的相对剩余酶活力及温度稳定性;使用不同pH值(2.0、3.0、4.0、5.0、6.0、7.0、8.0、9.0、10.0、11.0)的缓冲液测定不同pH条件下重组酵母全细胞的相对酶活力;将重组酵母全细胞在不同pH条件下,4℃放置处理1h后,测定剩余相对酶活力以及pH稳定性。Using the specific tannin with the highest catalytic activity as the substrate, the optimal reaction temperature of the recombinant yeast whole cells was determined in the temperature range of 10-90 °C under the optimal pH value; similarly, the recombinant yeast whole cells were treated at different temperatures After 1 hour of treatment under the same conditions, the relative remaining enzyme activity and temperature stability after treatment at different temperatures were measured; using buffer solutions with different pH values (2.0, 3.0, 4.0, 5.0, 6.0, 7.0, 8.0, 9.0, 10.0, 11.0) The relative enzyme activity of recombinant yeast whole cells under different pH conditions; after the recombinant yeast whole cells were placed at 4°C for 1 hour under different pH conditions, the remaining relative enzyme activity and pH stability were measured.
本发明中所用试剂或仪器均可由市场购得。All reagents and instruments used in the present invention can be purchased from the market.
下面结合实施例,进一步阐述本发明:Below in conjunction with embodiment, further set forth the present invention:
实施例1Example 1
罗布麻单宁酶基因为序列表SEQ ID NO:1所示的核苷酸序列;罗布麻单宁酶为序列表SEQ ID NO:2所示氨基酸序列。The apocynum tannase gene is the nucleotide sequence shown in SEQ ID NO: 1 in the sequence table; the apocynum tannase gene is the amino acid sequence shown in SEQ ID NO: 2 in the sequence table.
一、合成序列表SEQ ID NO:1所示的核苷酸序列1. Synthesis of the nucleotide sequence shown in SEQ ID NO: 1 in the sequence listing
(1)罗布麻叶片样品总RNA的提取(1) Extraction of total RNA from Apocynum leaf sample
罗布麻叶片样品总RNA的提取按照Promega公司RNA抽提试剂盒TotalRNA Kit II(50)的说明书进行并略做修改。对于所用到的塑料器皿均用DEPC(焦碳酸二乙酯)水处理;玻璃器皿在180℃烘烤6h;其他所有的试剂也均用DEPC处理水配制,121℃高温灭菌20min。The total RNA of Apocynum leaf samples was extracted according to the RNA extraction kit of Promega Company The instructions for the TotalRNA Kit II (50) were carried out with minor modifications. The plastic utensils used were treated with DEPC (diethylpyrocarbonate) water; the glass utensils were baked at 180°C for 6h; all other reagents were also prepared with DEPC-treated water, and sterilized at 121°C for 20min.
①取罗布麻叶片样品约100mg,用DEPC处理水洗净后放入到液氮预冷的研钵中立即加入液氮研磨成粉末;①Take about 100 mg of Apocynum leaf sample, wash it with DEPC treated water, put it into a mortar pre-cooled with liquid nitrogen, and immediately add liquid nitrogen to grind it into powder;
②在液氮未挥发完之前立即加入1mL的Reagent提取液继续研磨匀浆,并将匀浆转入经DEPC水处理过的1.5mL离心管中,加入0.2mL的氯仿,剧烈摇动离心管15s,静置5min;② Immediately add 1mL of liquid nitrogen before the liquid nitrogen evaporates Continue grinding and homogenizing the Reagent extract, transfer the homogenate into a 1.5mL centrifuge tube treated with DEPC water, add 0.2mL of chloroform, shake the centrifuge tube vigorously for 15 seconds, and let stand for 5 minutes;
③在4℃条件下,12000×g离心15min,溶液分为三层,下层为酚-氯仿液相,中间为一层白色的膜状物,上层为水相。将上层的水相移入另一个经DEPC处理过的1.5mL离心管中,加入其1/3体积的无水乙醇快速漩涡混合15s;③Centrifuge at 12000×g for 15 min at 4°C, the solution is divided into three layers, the lower layer is a phenol-chloroform liquid phase, the middle layer is a white film, and the upper layer is an aqueous phase. Transfer the upper aqueous phase into another DEPC-treated 1.5mL centrifuge tube, add 1/3 volume of absolute ethanol and vortex quickly for 15s;
④取步骤③中的上层水相的混合溶液700μL加入收集柱中,室温,12000×g离心30-60s,弃去流出液;④ Take 700 μL of the mixed solution of the upper aqueous phase in
⑤加入700μL RNA Wash Buffer洗涤液,室温,12000×g离心1min,弃去流出液,并重复该洗涤步骤一次;⑤ Add 700 μL RNA Wash Buffer, centrifuge at 12000×g for 1 min at room temperature, discard the effluent, and repeat this washing step once;
⑥取经DEPC水处理过的1.5mL离心管置于收集柱上,加30-50μL的70℃预热的DEPC水,室温孵育5min,室温≥13000×g离心2min,所得RNA溶液经检测后置于-70℃冰箱保存备用。总RNA变性琼脂糖胶电泳结果如图1所示,可见清晰的28S、18S和5.8S特征性带型,表明RNA完整性较好,未发生明显降解。⑥Put a 1.5mL centrifuge tube treated with DEPC water on the collection column, add 30-50μL of 70°C preheated DEPC water, incubate at room temperature for 5 minutes, and centrifuge at room temperature ≥13000×g for 2 minutes. The obtained RNA solution is tested and placed in Store in -70°C refrigerator for later use. The results of denatured agarose gel electrophoresis of total RNA are shown in Figure 1. Clear characteristic band patterns of 28S, 18S and 5.8S can be seen, indicating that the integrity of the RNA is good and no significant degradation has occurred.
(2)反转录合成罗布麻叶片样品cDNA(2) cDNA synthesis of Apocynum leaf sample by reverse transcription
根据TAKARA公司反转录试剂盒Reverse Transcritase M-MLV说明书进行cDNA的第一链的合成。对于所用的试剂均用DEPC处理水配制,所有实验操作都于超净工作台中进行。The first strand of cDNA was synthesized according to the instructions of Reverse Transcritase M-MLV, a reverse transcription kit from TAKARA Company. All reagents used were prepared with DEPC-treated water, and all experimental operations were carried out in a clean bench.
首先,在DEPC水处理过的0.2mL离心管中加入:总1μL RNA(100μg/mL),1μL Oligo(dT)12-18(50μM),5μL RNase free ddH2O,混匀并短暂离心后,在70℃温浴5min后立即置于冰上10min以上,短暂离心数秒使混合好的溶液全部聚集于离心管底部,并加入2μL 5×M-MLV Buffer,0.5μL dNTP Mix(10Mm),0.25μL RNase Inhibitor(40U/μL),0.25μL RTaseM-MLV(RNase H-)(200U/μL)。混匀后,42℃温浴60min,短暂离心,置于70℃保温15min后冰上冷却,得到的cDNA溶液用于PCR扩增。First, add: total 1 μL RNA (100 μg/mL), 1 μL Oligo(dT)12-18 (50 μM), 5 μL RNase free ddH 2 O to a 0.2 mL centrifuge tube treated with DEPC water, mix well and centrifuge briefly, After incubating at 70°C for 5 minutes, place it on ice for more than 10 minutes, centrifuge briefly for a few seconds so that all the mixed solution is collected at the bottom of the centrifuge tube, and add 2
(3)PCR反应扩增罗布麻单宁酶基因(3) PCR reaction amplification apocynum tannase gene
以上述cDNA为模板,根据罗布麻叶片样品转录组测序unigene序列设计引物,引物中分别引入EcoRI与HindIII酶切位点,用于扩增罗布麻单宁酶基因cDNA序列。Using the above cDNA as a template, primers were designed according to the unigene sequence of the transcriptome sequencing of Apocynum leaf samples, and EcoRI and HindIII restriction sites were introduced into the primers to amplify the cDNA sequence of Apocynum tannase gene.
上游引物1:5’GGAATTCATGGGTTGCCCTTGTGGAAAC 3’Upstream primer 1: 5'G GAATTC ATGGGTTGCCCTTGTGGAAAC 3'
下游引物2:5’CAAGCTTTTGATTGCAAGAGCAGCTTGAG3’Downstream primer 2: 5'C AAGCTT TTGATTGCAAGAGCAGCTTGAG3'
PCR反应体系:2μL cDNA模板,25μL 2×PrimerSTAR Max DNA Polymerase,1μL引物1,1μL引物2,补ddH2O至总反应体系为50μL。反应程序:①94℃,5min;②94℃,15s;③55℃,15s;④72℃,30s;⑤重复步骤②-④25个循环;⑥72℃,10min;PCR reaction system: 2 μL cDNA template, 25
取5μLPCR扩增产物加6×上样缓冲液,进行琼脂糖凝胶电泳检测。PCR产物送至测序公司测序。Take 5 μL of PCR amplification product and add 6× loading buffer for agarose gel electrophoresis detection. The PCR products were sent to a sequencing company for sequencing.
本实施方式中获得的罗布麻单宁酶基因cDNA全长1026bp,起始密码子为ATG,终止密码子为TGA,该序列无内含子,具有完整的开放阅读框,编码341个氨基酸;具体核苷酸序列如下:The total length of the Apocynum tanninase gene cDNA obtained in this embodiment is 1026bp, the start codon is ATG, the stop codon is TGA, the sequence has no introns, has a complete open reading frame, and encodes 341 amino acids; The nucleotide sequence is as follows:
ATGGGGAAACGTCAGAAGTTTCCTGGTGTCAATGAAGAACTGCAGAAGATAATTGATGGAAATATGGATGAAGCGGGGGCAAGGAGGCGTGCTCGTGAGGCATTTAAGGATATTCAGCTTTCAATTGATCATGTCTTGTTCAAGATGCCATGCAAGGGTTTGAAGATGAAGGAGTCATATGAAGTGAACTCTAAAGGATTGGAAATTTTCACGAAAAGTTGGCTTCCGGAGGCCAGTTCTCCAAAAGCAGTGGTTTTTTTTTGTCATGGATATGGAGACACTTGCACCTTTTTCTTTGAAGGAATTGCTCGGAAGTTGGCAACTGCTGGTTATGGAGTATTTGCTATGGATTATCCGGGATTTGGTCTTTCTGACGGTCTTCATGCCTATATTCCAAACTTTGATGCACTGGTAGATGCTGTGATTGAGCATTATTCAAAAGTAAAAGACAATCCAGATTTCAGTTCTCTGCCAAGTTTCCTGTTCGGAGAATCTATGGGTGGAGCAATAGCTCTGAAGGTGCACCTGAAACAACCTGACTCATGGACTGGAGCTATTCTTGTTGCCCCTATGTGTAAAATTGCAGATGACATGGTTCCACCATGGGTGGTGACACAGTTTCTTATTGGTGTGGCAAAAGTTCTTCCAAGACATAAGTTAGTTCCACAAAAGGATTTAGCTGACTTGGCATTCAGAGATGAGAAGAAGAAAAAATTGGCAAAATACAATGTAATTGCTTATAAGCATAAACCACGTTTACGAACAGCTGTGGAGATGCTGAACACCACCCAGGAGATAGAGCAAACATTGGAAAAAGTATCTTTGCCATTGTTGATCCTTCATGGGAAGGCTGATGTAATTACTGATCCATCTGTAAGTAAGGCCTTATATGAGAAAGCAAGCAGTACAGACAAGAAACTTATTCTCTATGATGATGCTTATCATTCTCTTCTTGAGGGTGAGCCAGATGAGATGATTCTCAAAGTGTTTGGAGACATAATTTCTTGGTTAGATGCTCATAGTTGAATGGGGAAACGTCAGAAGTTTCCTGGTGTCAATGAAGAACTGCAGAAGATAATTGATGGAAATATGGATGAAGCGGGGGCAAGGAGGCGTGCTCGTGAGGCATTTAAGGATATTCAGCTTTCAATTGATCATGTCTTGTTCAAGATGCCATGCAAGGGTTTGAAGATGAAGGAGTCATATGAAGTGAACTCTAAAGGATTGGAAATTTTCAC GAAAAGTTGGCTTCCGGAGGCCAGTTTCTCCAAAAGCAGTGGTTTTTTTTGTCATGGATATGGAGACACTTGCACCTTTTTCTTTGAAGGAATTGCTCGGAAGTTGGCAACTGCTGGTTATGGAGTATTTGCTATGGATTATCCGGGATTTGGTCTTTCTGACGGTCTTCATGCCTATATTCCAAACTTTGATGCACTGGTAGATGCTGTGATTGAGC ATTATTCAAAAAGTAAAAGACAATCCAGATTTCAGTTCTCTGCCAAGTTTCCTGTTCGGAGAATCTATGGGTGGAGCAATAGCTCTGAAGGTGCACCTGAAACAACCTGACTCATGGACTGGAGCTATTCTTGTTGCCCCTATGTGTAAAATTGCAGATGACATGGTTCCACCATGGGTGGTGACACAGTTTCTTATTGGTGTGGCAAAAGTTCTTCCAAGACATAAGT TAGTTCCACAAAGGATTTAGCTGACTTGGCATTCAGAGATGAGAAGAAGAAAAAATTGGCAAAATACAATGTAATTGCTTATAAGCATAAACCACGTTTACGAACAGCTGTGGAGATGCTGAACACCCACCAGGAGATAGAGCAAACATTGGAAAAAGTATCTTTGCCATTGTTGATCCTTCATGGGAAGGCTGATGTAATTACTGATCCATCTGTAAGTAAGG CCTTATATGAGAAAGCAAGCAGTACAGACAAAGAAACTTATTCTCTATGATGATGCTTATCATTCTCTTGAGGGTGAGCCAGATGAGATGATTCTCAAAGTGTTTGGAGACATAATTTCTTGGTTAGATGCTCATAGTTGA
具体氨基酸序列如下:The specific amino acid sequence is as follows:
MGKRQKFPGVNEELQKIIDGNMDEAGARRRAREAFKDIQLSIDHVLFKMPCKGLKMKESYEVNSKGLEIFTKSWLPEASSPKAVVFFCHGYGDTCTFFFEGIARKLATAGYGVFAMDYPGFGLSDGLHAYIPNFDALVDAVIEHYSKVKDNPDFSSLPSFLFGESMGGAIALKVHLKQPDSWTGAILVAPMCKIADDMVPPWVVTQFLIGVAKVLPRHKLVPQKDLADLAFRDEKKKKLAKYNVIAYKHKPRLRTAVEMLNTTQEIEQTLEKVSLPLLILHGKADVITDPSVSKALYEKASSTDKKLILYDDAYHSLLEGEPDEMILKVFGDIISWLDAHSMGKRQKFPGVNEELQKIIDGNMDEAGARRRAREAFKDIQLSIDHVLFKMPCKGLKMKESYEVNSKGLEIFTKSWLPEASSPKAVVFFCHGYGDTCTFFFEGIARKLATAGYGVFAMDYPGFGLSDGLHAYIPNFDAVDAVIEHYSKVKDNDFSSLPSFLFGESMGGAIALKVHLKQPDSWTGA ILVAPMCKIADDMVPPWVVTQFLIGVAKVLPRHKLVPQKDLADLAFRDEKKKKLAKYNVIAYKHKPRLRTAVEMLNTTQEIEQTLEKVSLPLLILHGKADVITDPSVSKALYEKASSTDKKLILYDDAYHSLLEGEPDEMILKVFGDIISWLDAHS
二、构建pYD1-avta穿梭载体以及全细胞催化剂工程菌2. Construction of pYD1-avta shuttle carrier and whole-cell catalyst engineering bacteria
将PCR扩增产物纯化回收后与pYD1穿梭载体分别进行双酶切,双酶切产物纯化回收后采用T4 DNA连接酶16℃过夜连接,得到重组表达载体连接产物。连接体系为:2μL罗布麻单宁酶基因双酶切回收产物,6μL pET-30a双酶切回收产物,1μL 10×T4 DNA连接酶buffer,1μL T4 DNA连接酶。After purification and recovery of the PCR amplification product, it was subjected to double enzyme digestion with the pYD1 shuttle vector. After the double enzyme digestion product was purified and recovered, it was ligated with T4 DNA ligase overnight at 16°C to obtain the recombinant expression vector ligation product. The ligation system is: 2 μL of product recovered from double digestion of Apocynum tannase gene, 6 μL of product recovered from double digestion of pET-30a, 1 μL of 10×T4 DNA ligase buffer, and 1 μL of T4 DNA ligase.
将构建好的穿梭表达载体连接产物与50μL大肠杆菌感受态细胞(E.coli DH5α)混匀,冰浴30min,然后42℃水浴90s,迅速取出后再次冰浴5min;然后再加入600μL LB液体培养基,37℃、150rpm振荡培养1h;取200μL菌液于LB固体培养基(含卡那霉素50mg/L)上均匀的涂布,37℃过夜培养,得到克隆菌落。Mix the constructed shuttle expression vector ligation product with 50 μL of Escherichia coli competent cells (E.coli DH5α), ice-bath for 30 minutes, then water-bath at 42°C for 90 seconds, take it out quickly, and ice-bath again for 5 minutes; then add 600 μL LB liquid culture medium, 37°C, 150rpm shaking culture for 1h; take 200μL of bacterial liquid on LB solid medium (containing kanamycin 50mg/L) and spread evenly, and culture overnight at 37°C to obtain clone colonies.
挑取单克隆菌落接种于2mL LB(含卡那霉素)培养液中37℃、250rpm振荡过夜,取1μL菌液进行菌落PCR初步鉴定,将阳性菌液抽提质粒(pYD1-avta)、进一步酶切(EcoRI/HindIII)鉴定正确后送样测序。测序正确的工程菌株进行诱导表达实验或加甘油至终浓度为10%,-70℃保存。Pick a monoclonal colony and inoculate it in 2 mL of LB (containing kanamycin) culture solution at 37°C and 250 rpm for overnight shaking, take 1 μL of the bacterial solution for preliminary identification by colony PCR, extract the plasmid (pYD1-avta) from the positive bacterial solution, and further After enzyme digestion (EcoRI/HindIII) was identified correctly, the sample was sent for sequencing. The engineered strains with correct sequencing were used for induction expression experiments or added glycerol to a final concentration of 10%, and stored at -70°C.
大量提取pYD1-avta质粒载体,并取约2μg的pYD-avta重组载体与50μL酿酒酵母EBY100感受态细胞混合均匀后,于1.5kV、25μF、200Ω条件下进行电击转化;然后将上述转化溶液接种到10mL SD-CAA培养基中30℃、250rpm过夜培养至菌液浓度OD600值达2~5。室温,5,000rpm离心5min收集菌体,并转移至20~40mL的SG-CAA诱导培养基中,20℃~25℃、250rpm诱导培养48h,然后取诱导后的菌体分别进行菌落PCR测序、免疫荧光及western-blotting等验证。获得细胞壁表面锚定氨基酸序列如SEQ ID NO:2所示罗布麻单宁酶的酿酒酵母全细胞单宁催化工程菌株。A large number of pYD1-avta plasmid vectors were extracted, and about 2 μg of pYD-avta recombinant vector was mixed with 50 μL of Saccharomyces cerevisiae EBY100 competent cells, and electric shock transformation was carried out under the conditions of 1.5kV, 25μF, 200Ω; then the above transformation solution was inoculated into Cultivate overnight in 10mL SD-CAA medium at 30°C and 250rpm until the OD600 value of the bacterial solution reaches 2-5. Centrifuge at room temperature at 5,000rpm for 5min to collect the bacterial cells, transfer them to 20-40mL SG-CAA induction medium, induce culture at 20°C-25°C, 250rpm for 48h, and then take the induced bacterial cells for colony PCR sequencing, immunization Fluorescence and western-blotting verification. The whole-cell tannin catalytic engineering strain of Saccharomyces cerevisiae whose cell wall surface-anchored amino acid sequence is shown in SEQ ID NO: 2 is obtained.
实施例2一种罗布麻单宁酶全细胞催化剂工程菌株底物活性分析Embodiment 2 A kind of Apocynum tannase whole cell catalyst engineering strain substrate activity analysis
取1μg pYD1-avta/S.cerevisiae EBY100全细胞催化剂工程菌株,分别加入终浓度为0.2mM的维生素C溶液、终浓度为300μM的表儿茶素没食子酸酯、没食子酸酰葡萄糖、没食子酸甲酯、没食子酸丙酯等底物溶液、以及pH7.4的磷酸缓冲溶液,至总反应体系为50μL;35℃,反应10min后,加入50μL甲醇反应终止液;4℃、12000g、离心15min后,取上清液进行液相色谱分析,检测反应后溶液中的底物以及相应产物的种类与含量。实验结果如图1所示,该全细胞催化剂工程菌对表儿茶素没食子酸酯、没食子酸酰葡萄糖、没食子酸甲酯、没食子酸丙酯等单宁底物均具催化活性。相应的酶动力学参数(Kcat/Km(S-1M-1))分别为:表儿茶素没食子酸酯77.86±1.12;没食子酸酰葡萄糖3.21±0.24、没食子酸甲酯6.43±0.51、没食子酸丙酯10.05±1.23。其中,该全细胞催化剂工程菌对儿茶素没食子酸酯类的单宁底物的催化效果显著高于其他类单宁底物。Take 1 μg pYD1-avta/S.cerevisiae EBY100 whole-cell catalyst engineering strain, add vitamin C solution with a final concentration of 0.2mM, epicatechin gallate, gallic acid acylglucose, and methyl gallate with a final concentration of 300μM , propyl gallate and other substrate solutions, and pH 7.4 phosphate buffer solution, until the total reaction system is 50 μL; 35 ° C, after 10 minutes of reaction, add 50 μ L of methanol reaction termination solution; The supernatant was analyzed by liquid chromatography to detect the types and contents of substrates and corresponding products in the solution after the reaction. The experimental results are shown in Figure 1. The whole-cell catalyst engineered bacteria have catalytic activity on tannin substrates such as epicatechin gallate, acyl gallate, methyl gallate, and propyl gallate. The corresponding enzyme kinetic parameters (Kcat/Km(S -1 M -1 )) are: epicatechin gallate 77.86±1.12; galloacylglucose 3.21±0.24; Propyl acid 10.05±1.23. Among them, the catalytic effect of the whole-cell catalyst engineering bacteria on catechin gallate-like tannin substrates is significantly higher than that of other tannin-like substrates.
实施例3一种罗布麻单宁酶全细胞催化剂工程菌株酶活力稳定性分析Embodiment 3 A kind of Apocynum tanninase whole cell catalyst engineering strain enzyme activity stability analysis
将罗布麻单宁酶全细胞催化剂工程菌株置于不同pH(2.0、3.0、4.0、5.0、6.0、7.0、8.0、9.0、10.0、11.0)的缓冲液中,按实施例2中的方法4℃放置处理1h后测定,测定不同pH条件下重组酵母全细胞的相对酶活力和PH稳定性。从图中2可以看出该罗布麻单宁酶全细胞催化剂工程菌株的最适合反应pH值为6.0,在pH 2~7之间的酶活稳定性较高,表现出80%以上的相对剩余酶活力。Apocynum tannase whole cell catalyst engineering strain is placed in the buffer solution of different pH (2.0, 3.0, 4.0, 5.0, 6.0, 7.0, 8.0, 9.0, 10.0, 11.0), according to the method in
在最适pH值条件下,于20~90℃的温度范围内测定罗布麻单宁酶全细胞催化剂工程菌株的最适反应温度;如图3所示其最适反应温度80℃,在80℃以下时酶活稳定性较高,表现出85%以上的相对剩余酶活力。Under optimum pH value condition, in the temperature scope of 20~90 ℃, measure the optimum reaction temperature of Apocynum tannase whole cell catalyst engineering bacterial strain; Its
实施例4一种罗布麻单宁酶全细胞催化剂工程菌株对罗布麻茶风味的改良效果Embodiment 4 A kind of Apocynum tanninase whole cell catalyst engineering strain improves the flavor of Apocynum tea flavor
将0.1%(克/毫升)的罗布麻单宁酶全细胞催化剂工程菌株,添加到10%(克/毫升)的罗布麻茶汤中,20分钟后茶汤中的酯型儿茶素含量趋于稳定,其中表儿茶素没食子酸酯含量的减少最为显著,相对于未添加单宁酶全细胞催化剂工程菌株的对照组含量减少了72.18%,且茶汤汤色明亮,香味纯正,口感醇和,略有苦涩味。该实施例中,罗布麻单宁酶全细胞催化剂工程菌株添加量在0-0.1%范围内,酶解时间在15-20分钟,可以达到茶汤滋味淡薄、香气纯正的最佳效果。Add 0.1% (g/ml) of Apocynum tanninase whole cell catalyst engineering bacterial strain to 10% (g/ml) of Apocynum tea soup, after 20 minutes, the ester type catechin content in the tea soup tends to be stable Among them, the reduction of epicatechin gallate content is the most significant, compared with the control group without adding tannase whole-cell catalyst engineering strain, the content is reduced by 72.18%, and the tea soup is bright in color, pure in fragrance, mellow in taste, slightly bitter taste. In this embodiment, the addition amount of the Apocynum tannase whole-cell catalyst engineered strain is in the range of 0-0.1%, and the enzymolysis time is 15-20 minutes, which can achieve the best effect of tea soup with light taste and pure aroma.
以上所述仅是本发明的优选实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。The above is only a preferred embodiment of the present invention, it should be pointed out that, for those of ordinary skill in the art, without departing from the principle of the present invention, some improvements and modifications can also be made, and these improvements and modifications can also be made. It should be regarded as the protection scope of the present invention.
序列表sequence listing
<110> 中国农业科学院麻类研究所<110> Institute of Hemp, Chinese Academy of Agricultural Sciences
<120> 一种罗布麻单宁酶全细胞催化剂工程菌株及其制备方法和应用<120> An engineering strain of apocynum tannase whole-cell catalyst and its preparation method and application
<130> MP21024538<130> MP21024538
<160> 2<160> 2
<170> SIPOSequenceListing 1.0<170> SIPOSequenceListing 1.0
<210> 1<210> 1
<211> 1026<211> 1026
<212> DNA<212>DNA
<213> 人工序列(Artificial Sequence)<213> Artificial Sequence
<400> 1<400> 1
atggggaaac gtcagaagtt tcctggtgtc aatgaagaac tgcagaagat aattgatgga 60atggggaaac gtcagaagtt tcctggtgtc aatgaagaac tgcagaagat aattgatgga 60
aatatggatg aagcgggggc aaggaggcgt gctcgtgagg catttaagga tattcagctt 120aatatggatg aagcgggggc aaggaggcgt gctcgtgagg catttaagga tattcagctt 120
tcaattgatc atgtcttgtt caagatgcca tgcaagggtt tgaagatgaa ggagtcatat 180tcaattgatc atgtcttgtt caagatgcca tgcaagggtt tgaagatgaa ggagtcatat 180
gaagtgaact ctaaaggatt ggaaattttc acgaaaagtt ggcttccgga ggccagttct 240gaagtgaact ctaaaggatt ggaaattttc acgaaaagtt ggcttccgga ggccagttct 240
ccaaaagcag tggttttttt ttgtcatgga tatggagaca cttgcacctt tttctttgaa 300ccaaaagcag tggtttttttttgtcatgga tatggagaca cttgcacctttttctttgaa 300
ggaattgctc ggaagttggc aactgctggt tatggagtat ttgctatgga ttatccggga 360ggaattgctc ggaagttggc aactgctggt tatggagtat ttgctatgga ttatccggga 360
tttggtcttt ctgacggtct tcatgcctat attccaaact ttgatgcact ggtagatgct 420tttggtcttt ctgacggtct tcatgcctat attccaaact ttgatgcact ggtagatgct 420
gtgattgagc attattcaaa agtaaaagac aatccagatt tcagttctct gccaagtttc 480gtgattgagc attattcaaa agtaaaagac aatccagatt tcagttctct gccaagtttc 480
ctgttcggag aatctatggg tggagcaata gctctgaagg tgcacctgaa acaacctgac 540ctgttcggag aatctatggg tggagcaata gctctgaagg tgcacctgaa acaacctgac 540
tcatggactg gagctattct tgttgcccct atgtgtaaaa ttgcagatga catggttcca 600tcatggactg gagctattct tgttgcccct atgtgtaaaa ttgcagatga catggttcca 600
ccatgggtgg tgacacagtt tcttattggt gtggcaaaag ttcttccaag acataagtta 660ccatgggtgg tgacacagtt tcttattggt gtggcaaaag ttcttccaag acataagtta 660
gttccacaaa aggatttagc tgacttggca ttcagagatg agaagaagaa aaaattggca 720gttccacaaa aggatttagc tgacttggca ttcagagatg agaagaagaa aaaattggca 720
aaatacaatg taattgctta taagcataaa ccacgtttac gaacagctgt ggagatgctg 780aaatacaatg taattgctta taagcataaa ccacgtttac gaacagctgt ggagatgctg 780
aacaccaccc aggagataga gcaaacattg gaaaaagtat ctttgccatt gttgatcctt 840aacaccacccc aggagataga gcaaacattg gaaaaagtat ctttgccatt gttgatcctt 840
catgggaagg ctgatgtaat tactgatcca tctgtaagta aggccttata tgagaaagca 900catgggaagg ctgatgtaat tactgatcca tctgtaagta aggccttata tgagaaagca 900
agcagtacag acaagaaact tattctctat gatgatgctt atcattctct tcttgagggt 960agcagtacag acaagaaact tattctctat gatgatgctt atcattctct tcttgagggt 960
gagccagatg agatgattct caaagtgttt ggagacataa tttcttggtt agatgctcat 1020gagccagatg agatgattct caaagtgttt ggagacataa tttcttggtt agatgctcat 1020
agttga 1026agttga 1026
<210> 2<210> 2
<211> 341<211> 341
<212> PRT<212> PRT
<213> 人工序列(Artificial Sequence)<213> Artificial Sequence
<400> 2<400> 2
Met Gly Lys Arg Gln Lys Phe Pro Gly Val Asn Glu Glu Leu Gln LysMet Gly Lys Arg Gln Lys Phe Pro Gly Val Asn Glu Glu Leu Gln Lys
1 5 10 151 5 10 15
Ile Ile Asp Gly Asn Met Asp Glu Ala Gly Ala Arg Arg Arg Ala ArgIle Ile Asp Gly Asn Met Asp Glu Ala Gly Ala Arg Arg Arg Ala Arg
20 25 30 20 25 30
Glu Ala Phe Lys Asp Ile Gln Leu Ser Ile Asp His Val Leu Phe LysGlu Ala Phe Lys Asp Ile Gln Leu Ser Ile Asp His Val Leu Phe Lys
35 40 45 35 40 45
Met Pro Cys Lys Gly Leu Lys Met Lys Glu Ser Tyr Glu Val Asn SerMet Pro Cys Lys Gly Leu Lys Met Lys Glu Ser Tyr Glu Val Asn Ser
50 55 60 50 55 60
Lys Gly Leu Glu Ile Phe Thr Lys Ser Trp Leu Pro Glu Ala Ser SerLys Gly Leu Glu Ile Phe Thr Lys Ser Trp Leu Pro Glu Ala Ser Ser
65 70 75 8065 70 75 80
Pro Lys Ala Val Val Phe Phe Cys His Gly Tyr Gly Asp Thr Cys ThrPro Lys Ala Val Val Phe Phe Cys His Gly Tyr Gly Asp Thr Cys Thr
85 90 95 85 90 95
Phe Phe Phe Glu Gly Ile Ala Arg Lys Leu Ala Thr Ala Gly Tyr GlyPhe Phe Phe Glu Gly Ile Ala Arg Lys Leu Ala Thr Ala Gly Tyr Gly
100 105 110 100 105 110
Val Phe Ala Met Asp Tyr Pro Gly Phe Gly Leu Ser Asp Gly Leu HisVal Phe Ala Met Asp Tyr Pro Gly Phe Gly Leu Ser Asp Gly Leu His
115 120 125 115 120 125
Ala Tyr Ile Pro Asn Phe Asp Ala Leu Val Asp Ala Val Ile Glu HisAla Tyr Ile Pro Asn Phe Asp Ala Leu Val Asp Ala Val Ile Glu His
130 135 140 130 135 140
Tyr Ser Lys Val Lys Asp Asn Pro Asp Phe Ser Ser Leu Pro Ser PheTyr Ser Lys Val Lys Asp Asn Pro Asp Phe Ser Ser Leu Pro Ser Phe
145 150 155 160145 150 155 160
Leu Phe Gly Glu Ser Met Gly Gly Ala Ile Ala Leu Lys Val His LeuLeu Phe Gly Glu Ser Met Gly Gly Ala Ile Ala Leu Lys Val His Leu
165 170 175 165 170 175
Lys Gln Pro Asp Ser Trp Thr Gly Ala Ile Leu Val Ala Pro Met CysLys Gln Pro Asp Ser Trp Thr Gly Ala Ile Leu Val Ala Pro Met Cys
180 185 190 180 185 190
Lys Ile Ala Asp Asp Met Val Pro Pro Trp Val Val Thr Gln Phe LeuLys Ile Ala Asp Asp Met Val Pro Pro Trp Val Val Thr Gln Phe Leu
195 200 205 195 200 205
Ile Gly Val Ala Lys Val Leu Pro Arg His Lys Leu Val Pro Gln LysIle Gly Val Ala Lys Val Leu Pro Arg His Lys Leu Val Pro Gln Lys
210 215 220 210 215 220
Asp Leu Ala Asp Leu Ala Phe Arg Asp Glu Lys Lys Lys Lys Leu AlaAsp Leu Ala Asp Leu Ala Phe Arg Asp Glu Lys Lys Lys Lys Lys Leu Ala
225 230 235 240225 230 235 240
Lys Tyr Asn Val Ile Ala Tyr Lys His Lys Pro Arg Leu Arg Thr AlaLys Tyr Asn Val Ile Ala Tyr Lys His Lys Pro Arg Leu Arg Thr Ala
245 250 255 245 250 255
Val Glu Met Leu Asn Thr Thr Gln Glu Ile Glu Gln Thr Leu Glu LysVal Glu Met Leu Asn Thr Thr Gln Glu Ile Glu Gln Thr Leu Glu Lys
260 265 270 260 265 270
Val Ser Leu Pro Leu Leu Ile Leu His Gly Lys Ala Asp Val Ile ThrVal Ser Leu Pro Leu Leu Ile Leu His Gly Lys Ala Asp Val Ile Thr
275 280 285 275 280 285
Asp Pro Ser Val Ser Lys Ala Leu Tyr Glu Lys Ala Ser Ser Thr AspAsp Pro Ser Val Ser Lys Ala Leu Tyr Glu Lys Ala Ser Ser Thr Asp
290 295 300 290 295 300
Lys Lys Leu Ile Leu Tyr Asp Asp Ala Tyr His Ser Leu Leu Glu GlyLys Lys Leu Ile Leu Tyr Asp Asp Ala Tyr His Ser Leu Leu Glu Gly
305 310 315 320305 310 315 320
Glu Pro Asp Glu Met Ile Leu Lys Val Phe Gly Asp Ile Ile Ser TrpGlu Pro Asp Glu Met Ile Leu Lys Val Phe Gly Asp Ile Ile Ser Trp
325 330 335 325 330 335
Leu Asp Ala His SerLeu Asp Ala His Ser
340 340
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111097968.7A CN113801863B (en) | 2021-09-18 | 2021-09-18 | A kind of engineering strain of apocynum tannase whole cell catalyst and its preparation method and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111097968.7A CN113801863B (en) | 2021-09-18 | 2021-09-18 | A kind of engineering strain of apocynum tannase whole cell catalyst and its preparation method and application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113801863A CN113801863A (en) | 2021-12-17 |
CN113801863B true CN113801863B (en) | 2023-06-23 |
Family
ID=78896066
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111097968.7A Active CN113801863B (en) | 2021-09-18 | 2021-09-18 | A kind of engineering strain of apocynum tannase whole cell catalyst and its preparation method and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113801863B (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1289665C (en) * | 2004-06-09 | 2006-12-13 | 中山大学 | Recombined aspergillus oryzae tannase and its expression and purification |
CN105010667B (en) * | 2015-07-05 | 2018-07-10 | 阿勒泰戈宝茶股份有限公司 | Sleeping dogbane tea and preparation method thereof |
CN107287223A (en) * | 2017-06-20 | 2017-10-24 | 江苏科技大学 | α L rhamnosides enzyme genes and its application |
CN109439558A (en) * | 2018-10-22 | 2019-03-08 | 中国农业科学院麻类研究所 | A kind of restructuring yeast strains and its construction method and application |
-
2021
- 2021-09-18 CN CN202111097968.7A patent/CN113801863B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN113801863A (en) | 2021-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101095442B (en) | Pu'er tea ointment and the producing technology thereof | |
CN110283805B (en) | A purple monascus ester synthase LIP05, encoding gene and application thereof | |
CN111154790B (en) | Oxysqualene cyclase gene GpOSC1 and its coding product and application | |
CN114634939B (en) | PgJMT1 gene for regulating synthesis of methyl jasmonate in ginseng and application thereof | |
CN102925317A (en) | Production method of hawthorn brandy | |
CN113373123A (en) | Tyrosinase mutant and application thereof | |
CN113801863B (en) | A kind of engineering strain of apocynum tannase whole cell catalyst and its preparation method and application | |
CN114606152A (en) | Bacillus belgii, microbial agent and application thereof | |
CN104804940B (en) | Multi-flavor kick type low-alcohol wine prepared from phyllanthus emblica L and preparation method of low-alcohol wine | |
CN102952878B (en) | ITS (Internal Transcribed Spacer) sequence and method for identifying certified lepidium meyenii walp and counterfeit lepidium meyenii walp as well as doped lepidium meyenii walp | |
CN110283806B (en) | Monascus purpureus ester synthetase LIP05-50, encoding gene and application thereof | |
CN108840949A (en) | From the peroxidase POD1 relevant to theaflavin generation of tealeaves and its application | |
CN101294153A (en) | A kind of aspergillus niger proline protein endopeptidase and preparation method thereof | |
CN114525212B (en) | An engineering strain of Monascus pilosa and its application | |
CN105586431B (en) | A kind of asparagus stem wilt bacteria molecular detection primer and rapid detection method | |
CN104928102A (en) | Method for producing white spirit by adopting fructus rosae laevigatae | |
CN108840948A (en) | From the peroxidase POD2 relevant to theaflavin generation of tealeaves and its application | |
CN115717131A (en) | Recombinant tyrosinase mutant and application thereof | |
CN107384656B (en) | Preparation method of Huoshan dendrobium officinale beer with high foamability and high foam retention | |
CN101693739A (en) | Chlorogenic acid synthesis associated protein and encoding gene thereof and application | |
WO2021076917A9 (en) | Genetically engineered yeast cells and methods of use thereof | |
CN116948849A (en) | Recombinant sake yeast for improving sake flavor and application of recombinant sake yeast in sake brewing | |
CN110343680A (en) | A kind of honeysuckle chalcone synthase mutant and application thereof | |
Ujihara et al. | Identification of material cultivar of green tea infusions by simple sequence repeat markers | |
CN109134629A (en) | Botrytis cinerea secreted protein exciton BcXyl1 and its application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |